BRCA1 and uterine cancer: The prevalence of BRCA mutation varied from 0% [18] to 27.2% [27] in patients with uterine cancer, and the currency of uterine cancer ranged from 0.53% [23] to 1.87% [30] in BRCA1/2 mutation carriers according to the baseline table.